CONTENTS
Company Overview
BioAssociates, Inc. is a marketing firm specializing in the life sciences industry, with a strong focus on the Japanese market. We provide customized market research and marketing support services tailored to help international businesses navigate and succeed in Japan’s unique bio-research equipment, reagent, and drug discovery support sectors. With deep expertise and a robust network within the Japanese life sciences community, we enable global organizations to effectively connect with Japanese researchers, institutions, and businesses, ensuring a smooth market entry and sustainable growth.
Core Competencies
Company Name | BioAssociates, Inc. |
Location | 3F Sanno Park Tower, 2-11-1 Nagatacho, Chiyoda-ku, Tokyo, Japan
|
Main Phone | +81-3-6205-3311 |
Founded | November 17, 2006 |
Capital | 10 million yen |
CEO | Yoshimitsu Obata |
Business Purpose |
|
Key Clients (Partial List) |
HMT Biomedical, PHC, Oji Holdings Corporation, Sysmex Corporation, Symphonia Technology, CellSeed Inc., Tosoh Corporation, Japan Tobacco Inc., Nichikabi Bios Corporation, Protenova Corporation, Mitsubishi Gas Chemical Company, Yamaha Motor Co., Ltd., Riken Genesis Co., Ltd., Agilent Technologies Japan, AB SCIEX, QIAGEN K.K., Corning International K.K., Sigma-Aldrich Japan, BioStream Inc., Bio-Rad Laboratories, Formulatrix LLC, Fluidigm Corporation, Nihon Waters K.K., Merck K.K., Roche Diagnostics K.K., 10x Genomics, GreenPharma S.A.S., Kagawa Industry Support Foundation, Hamamatsu Innovation Support Organization, Japan Analytical Instruments Manufacturers' Association, and more. |
Yoshimitsu Obata 【CEO】
After 13 years at the Japanese subsidiary of Applied Biosystems Inc. (now Thermo Fisher Scientific Inc.), where he led global marketing projects for genetic and protein analysis systems, Yoshimitsu Obata founded BioAssociates in 2003. As a specialized marketing firm in the bio-business field, the company supports clients domestically and internationally in business consulting, market research, and marketing communications.
He has also served in numerous public roles, including as an expert for METI's University-Originated Venture Business Management Support Program (since 2004), Kagawa Prefecture's Glycobio Cluster Formation Project Science Technology Coordinator (since 2005), NEDO Technology Management Advisor (since 2007), and JETRO RIT Program Overseas Research Specialist (since 2008).
Osamu Muraoka 【Scientific Advisor】
Professor Emeritus at Kinki University (former Vice President, Director of the Anti-Aging Center, and Dean of the Faculty of Pharmacy).
Appointed as Scientific Advisor to BioAssociates, Inc. in 2019.
Provides technical advisory services on discovering and scientifically evaluating bioactive compounds in natural products and their application to healthcare products (pharmaceuticals, functional cosmetics, and functional foods).
Shinobu Omi 【Scientific Advisor】
Former Associate Professor at the Institute of Medical Science, University of Tokyo, specializing in Disease Proteomics Laboratory. Key publications include "Peptide Antibody Protocol" (Shujunsha), a series on "Lab Tips" in Cell Engineering Magazine (Shujunsha), and "Peptide Antibody Basics" (Cell Engineering Magazine, Special Edition).
Since joining BioAssociates, Inc. in 2015, he has written the popular "Antibody Stories" for BioMarket.jp and provided technical advisory services based on his extensive experience.
Michael D. O’Neill 【Science Writer/BioQuick News Editor-in-Chief】
Science writer and independent media editor-in-chief at BioQuick News, read in over 160 countries. BioQuick News has received the U.S. APEX Award for Publication Excellence in 2010, 2011, and 2012. Known for his expertise in life sciences and medical writing, including contributions to Applied Biosystems’ BioBeat Online Magazine.
Earned a Master’s degree in Immunology and Microbiology from Duke University.
Roshini Beenukumar 【Medical Writer】
Transitioned from a molecular biology researcher to a medical writer. During her doctoral studies, she investigated cancer cell behavior using artificial synthetic yeast. Currently, she works as a medical writer specializing in medical communications and marketing writing for the healthcare, life sciences, and biotechnology industries. She is a member of the European Medical Writers Association and is passionate about disseminating new ideas at the intersection of medicine and technology.
Earned a Ph.D. in Life Sciences and Genetics from the University of Cologne.
Inquiry Form
For more information about our company or services, feel free to contact us: